Jb Chemicals To Expand Facilities In Daman

JB Chemicals & Pharmaceuticals, which manufactures Doktor Mom lozenges and tablets, has decided to scale up investments in its facilities in Daman from Rs 15 crore to Rs 25 crore.

The new facilities will have an installed capacity to manufacture 100 crore lozenges and 75 crore tablets per annum on a single shift basis.

The export-oriented unit will enable JB Chemicals to cater to the increasing demand for Doktor Mom lozenges from Russian, Ukrainian, Sri Lankan, African and Latin American markets.

Both plants, which have been built at a revised projected cost of Rs 25 crore from the earlier envisaged Rs 15 crore, will be financed through internal accruals.

 

The plants are expected to go on stream in 2003. Profits derived from the EOU will be tax-free until assessment year 2009-10, while profits from the tablets plant will be tax-free in the first five years from 2003-04. Thirty per cent of the profits will be tax free for the next five years.

The entire project will have an attractive payback, J B Mody, chairman of JB Chemicals, said.

In addition to these two plants, the company has modern manufacturing facilities at various locations in the country, that produce a wide range of small/large volume parentals, tablets, capsules, cartridges, liquids, ointments, herbal remedies, intermediates, bulk drugs and radio-diagnostics.

This apart, the company, which has two research and development centres, holds 17 international patents and exports its products to over 34 countries across the world.